Previous Article | Next Article ![]()
J. Virol., 04 1997, 2600-2605, Vol 71, No. 4
S Laeeq, CA Smith, SD Wagner and DB Thomas
An analysis was made of the neutralizing antibody repertoire, for influenza
virus hemagglutinin (HA) of transgenic mice expressing a human
immunoglobulin mu (IgH) minigene, by monoclonal antibody (MAb) selection
and sequencing of the HA genes of X31 (H3N2 subtype) laboratory variants.
Whereas previously reported laboratory variants, selected in ovo with
high-affinity murine MAbs of the IgG class, differed from wild-type virus
by a single amino acid residue change in one of the major antigenic sites,
neutralizing MAbs from transgenic donors selected novel variant viruses
with altered receptor-binding specificity and contained residue changes in
both the receptor-binding pocket (HA1 225 or HA1 226) and an antigenic site
(HA1 135, HA1 145, or HA1 158). Changes in receptor-binding specificities
of the variant viruses were confirmed by their resistance to inhibition by
horse serum glycoproteins and altered binding to neoglycoproteins. The
residue changes in variant virus V-21.2 (HA1 135 G-->R, 225 G-->D)
abrogated neutralization by each of the MAbs; nevertheless V-21.2 was
recognized by its own selecting MAb in enzyme-linked immunosorbent assay
and therefore qualified as an adsorptive mutant rather than an antigenic
variant. We consider that a low-affinity neutralizing antibody response may
preferentially select for receptor-binding variants of influenza virus HA.
Copyright © 1997, American Society for Microbiology
Preferential selection of receptor-binding variants of influenza virus hemagglutinin by the neutralizing antibody repertoire of transgenic mice expressing a human immunoglobulin mu minigene
National Institute for Medical Research, London, United Kingdom.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|